HL7 Portugal FHIR Implementation Guide para alergias e reacções adversas ao medicamento
1.0.0-ballot - CI Build Portugal flag

HL7 Portugal FHIR Implementation Guide para alergias e reacções adversas ao medicamento, published by HL7 Portugal. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-pt/adr-ig/ and changes regularly. See the Directory of published versions

Resource Profile: InformacaoMedicamento - Mappings

Active as of 2024-12-09

Mappings for the InformacaoMedicamento resource profile.

Mappings for Workflow Pattern (http://hl7.org/fhir/workflow)

InformacaoMedicamento
MedicationStatementEvent
   identifierEvent.identifier
   statusEvent.status
   medicationEvent.code
   subjectEvent.subject
   encounterEvent.encounter
   effective[x]Event.occurrence[x]
   reasonEvent.reason
   noteEvent.note

Mappings for FiveWs Pattern Mapping (http://hl7.org/fhir/fivews)

InformacaoMedicamento
MedicationStatementclinical.medication
   identifierFiveWs.identifier
   statusFiveWs.status
   categoryFiveWs.class
   medicationFiveWs.what[x]
   subjectFiveWs.subject[x]
   effective[x]FiveWs.done[x]
   dateAssertedFiveWs.recorded
   informationSourceFiveWs.source
   reasonFiveWs.why[x]

Mappings for RIM Mapping (http://hl7.org/v3)

InformacaoMedicamento
MedicationStatementEntity, Role, or Act,SubstanceAdministration
   textAct.text?
   containedN/A
   extensionN/A
   modifierExtensionN/A
   identifier.id
   partOf.outboundRelationship[typeCode=COMP]/target[classCode=SPLY or SBADM or PROC or OBS,moodCode=EVN]
   status.statusCode
   category.inboundRelationship[typeCode=COMP].source[classCode=OBS, moodCode=EVN, code="type of medication statement"].value
   medication.participation[typeCode=CSM].role[classCode=ADMM or MANU]
   subject.participation[typeCode=SBJ].role[classCode=PAT]
   encounter.inboundRelationship[typeCode=COMP].source[classCode=ENC, moodCode=EVN, code="type of encounter or episode"]
   effective[x].effectiveTime
   dateAsserted.participation[typeCode=AUT].time
   informationSource.participation[typeCode=INF].role[classCode=PAT, or codes for Practitioner or Related Person (if PAT is the informer, then syntax for self-reported =true)
   derivedFrom.outboundRelationship[typeCode=SPRT]/target[classCode=ACT,moodCode=EVN]
   reason.reasonCode
   note.inboundRelationship[typeCode=SUBJ]/source[classCode=OBS,moodCode=EVN,code="annotation"].value
   relatedClinicalInformationTBD
   renderedDosageInstructionSubstanceAdministration.text
   dosagerefer dosageInstruction mapping
      idn/a
      extensionn/a
      modifierExtensionN/A
      sequence.text
      text.text
      additionalInstruction.text
      patientInstruction.text
      timing.effectiveTime
      asNeeded.outboundRelationship[typeCode=PRCN].target[classCode=OBS, moodCode=EVN, code="as needed"].value=boolean or codable concept
      asNeededFor.outboundRelationship[typeCode=PRCN].target[classCode=OBS, moodCode=EVN, code="as needed"].value=boolean or codable concept
      site.approachSiteCode
      route.routeCode
      methodSubstanceAdministration.methodCode
      doseAndRateSubstanceAdministration.doseQuantity; SubstanceAdministration.RateQuantity
         idn/a
         extensionn/a
         dose[x].doseQuantity
         rate[x].rateQuantity
      maxDosePerPeriod.maxDoseQuantity
      maxDosePerAdministrationnot supported
      maxDosePerLifetimenot supported
   adherenceoutboundRelationship[typeCode=PERT].target[classCode=OBV,moodCode=EVN].value[xsi:type=BL]
      idn/a
      extensionn/a
      modifierExtensionN/A
      codeoutboundRelationship[typeCode=PERT].target[classCode=OBV,moodCode=EVN].value[xsi:type=BL]
      reason.inboundRelationship[typeCode=SUBJ].source[classCode=CACT, moodCode=EVN].reasonCode

Mappings for HL7 V2 Mapping (http://hl7.org/v2)

InformacaoMedicamento
MedicationStatement
   subjectPID-3 Patient ID List
   dosage
      sequenceTQ1-1
      textRXO-6; RXE-21
      additionalInstructionRXO-7
      patientInstructionRXO-7
      asNeededTQ1-9
      asNeededForTQ1-9
      siteRXR-2
      routeRXR-1
      methodRXR-4
      doseAndRateTQ1-2
         typeRXO-21; RXE-23
         dose[x]RXO-2, RXE-3
         rate[x]RXE22, RXE23, RXE-24
      maxDosePerPeriodRXO-23, RXE-19